Thrombotic thrombocytopenic purpura: genes and variants
Explore variant evidence for Thrombotic thrombocytopenic purpura across 2 analyzed proteins (ADAMTS13, VWF). Linked ClinVar records include 34 pathogenic or likely pathogenic variants, 149 variants of uncertain significance and 42 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-03. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Thrombotic thrombocytopenic purpura
ADAMTS13: A disintegrin and metalloproteinase with thrombospondin motifs 13
It cleaves ultra-large von Willebrand factor multimers in the circulation, preventing excessive platelet adhesion in small vessels. Severe inherited deficiency or inhibitory autoantibodies cause thrombotic thrombocytopenic purpura, characterized by microvascular thrombosis, thrombocytopenia, and hemolytic anemia.
34 ClinVar pathogenic / likely pathogenic and 191 uncertain variants in ADAMTS13 have source records linked to Thrombotic thrombocytopenic purpura. Association strength is not clinical gene validity.
VWF: von Willebrand factor
It tethers platelets to damaged vessel walls and carries factor VIII in the circulation, linking primary hemostasis with coagulation. Quantitative or qualitative pathogenic variants cause von Willebrand disease, the most common inherited bleeding disorder.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in VWF have source records linked to Thrombotic thrombocytopenic purpura. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Thrombotic thrombocytopenic purpura
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ADAMTS13 A596V | 596 | Spacer | Pathogenic / likely pathogenic (★★★★) |
| ADAMTS13 R1060W | 1060 | TSP type-1 7 | Pathogenic / likely pathogenic (★★★★) |
| ADAMTS13 R398C | 398 | TSP type-1 1 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 T196I | 196 | Peptidase M12B | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 C1024G | 1024 | TSP type-1 7 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 R102H | 102 | Peptidase M12B | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 R349C | 349 | Disintegrin | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 R1123C | 1123 | TSP type-1 8 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 I1217T | 1217 | CUB 1 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 P353L | 353 | Disintegrin | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 R498C | 498 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 A690T | 690 | TSP type-1 2 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 R1219Q | 1219 | CUB 1 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 R692C | 692 | TSP type-1 2 | Pathogenic / likely pathogenic (★★) |
| ADAMTS13 C1084Y | 1084 | TSP type-1 8 | Pathogenic / likely pathogenic (★) |
| ADAMTS13 D235H | 235 | Peptidase M12B | Pathogenic / likely pathogenic (★) |
| ADAMTS13 C1213R | 1213 | CUB 1 | Pathogenic / likely pathogenic (★) |
| ADAMTS13 R398H | 398 | TSP type-1 1 | Pathogenic / likely pathogenic (★) |
| ADAMTS13 L232Q | 232 | Peptidase M12B | Pathogenic / likely pathogenic (★) |
| ADAMTS13 E641K | 641 | Spacer | Pathogenic / likely pathogenic (★) |
| ADAMTS13 C758R | 758 | TSP type-1 3 | Pathogenic / likely pathogenic (★) |
| ADAMTS13 S119F | 119 | Peptidase M12B | Pathogenic / likely pathogenic (★) |
| ADAMTS13 R193W | 193 | Peptidase M12B | Pathogenic / likely pathogenic (★) |
| ADAMTS13 I673F | 673 | Spacer | Pathogenic / likely pathogenic (★) |
| ADAMTS13 G1239R | 1239 | CUB 1 | Pathogenic / likely pathogenic (★) |
| ADAMTS13 C1213Y | 1213 | CUB 1 | Pathogenic / likely pathogenic |
| ADAMTS13 H96D | 96 | Peptidase M12B | Pathogenic / likely pathogenic |
| ADAMTS13 C508Y | 508 | Cysteine-rich | Pathogenic / likely pathogenic |
| ADAMTS13 A250V | 250 | Peptidase M12B | Pathogenic / likely pathogenic |
| ADAMTS13 C710W | 710 | TSP type-1 2 | Pathogenic / likely pathogenic |
| ADAMTS13 C737R | 737 | Pathogenic / likely pathogenic | |
| ADAMTS13 R268P | 268 | Peptidase M12B | Pathogenic / likely pathogenic |
| ADAMTS13 C951G | 951 | TSP type-1 6 | Pathogenic / likely pathogenic |
| ADAMTS13 Q448E | 448 | Cysteine-rich | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Thrombotic thrombocytopenic purpura
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| ADAMTS13 D235Y | 235 | Peptidase M12B | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; D235H at the same position is pathogenic; seen in 6.8e-06 of gnomAD DNA copies; REVEL 0.943 |
Which prediction tools work for Thrombotic thrombocytopenic purpura
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 93 out of 100
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 90 out of 100
- SIFT: 90 out of 100
- MetaLR: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 89 out of 100
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 81 out of 100
- SpliceAI: 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 40 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Thrombotic thrombocytopenic purpura
- Hypertrophic cardiomyopathy, also linked to VWF
- Noonan syndrome, also linked to VWF
- Von Willebrand disease, also linked to VWF
Frequently asked questions
Which genes have records linked to Thrombotic thrombocytopenic purpura?
This view contains 2 analyzed proteins: ADAMTS13, VWF. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 34 pathogenic or likely pathogenic variants, 149 variants of uncertain significance and 42 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 265 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center